Versigent Q2 Adjusted EPS, Revenue Rise; Shares Gain Pre-Bell
MT Newswires Live
Aug 04
Versigent (VGNT) reported Q2 adjusted earnings Tuesday of $1.92 per diluted share, up from $1.89 a year earlier.
Two analysts polled by FactSet expected $1.63.
Net sales for the quarter ended June 30 were $2.44 billion, up from $2.21 billion a year earlier. Analysts expected $2.33 billion.
The company raised and tightened its full-year 2026 net sales guidance to $9.4 billion to $9.6 billion from $9.1 billion to $9.4 billion. Analysts expect $9.3 billion.
The company's shares were up more than 10% in premarket trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.